New hope for lung cancer patients Who've run out of options?
Disease control
Recruiting now
This phase 2 trial tests a new drug called nelmastobart combined with the chemotherapy docetaxel in 62 people with advanced non-small cell lung cancer that no longer responds to platinum chemo or immunotherapy. The goal is to see if the combination can slow cancer growth and impr…
Phase: PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC